Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
   11  Agents affecting central nervous system
   12  Agents affecting peripheral nervous system
     121  Local anesthetics
       1211  Aminobenzoate alkamine esters
       1212  Aminobenzoate alkyl esters
       1213  Dibucaines
       1214  Xylidines
         D00358  Lidocaine (JP17/USP/INN)
         D02086  Lidocaine hydrochloride (JAN/USP)
         D08127  Lidocaine hydrochloride monohydrate
         D01450  Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP17)
         D00738  Mepivacaine hydrochloride (JP17/USP)
         D04048  Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN)
         D01287  Levobupivacaine hydrochloride (JAN/USAN)
         D04052  Epinephrine and lidocaine hydrochloride
C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01
C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01
C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01
N01BB01
N01BB03
N01BB09
N01BB10
 
       1215  Alkaloids
       1219  Others
     122  Skeletal muscle relaxants
     123  Autonomic nervous system agents
     124  Antispasmodics
     125  Diaphoretics, anhidrotics
     129  Miscellaneous
   13  Agents affecting sensory organs
   19  Other agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 21, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version